Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The study is intended to test efficacy, safety and tolerability of two doses of YM178 against
placebo and tolterodine to treat patients with symptoms of over active bladder.